Diarrhea News and Research

Latest Diarrhea News and Research

On-site pathology testing benefits remote Australians and helps save millions

On-site pathology testing is allowing remote Australians to receive effective emergency medical treatment close to home, while saving millions according to researchers.

12 Jun 2018

New FDA-approved therapy provides better quality of life for patients with midgut neuroendocrine tumors

Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.

12 Jun 2018

Cedars-Sinai study identifies gut gas associated with diarrhea

Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses - small intestine bacterial overgrowth and irritable bowel syndrome.

6 Jun 2018

Researchers explore targeted second-line treatment for colorectal cancer

Targeted therapy with anti-VEGF and anti-EGFR antibodies both improve outcomes when added to chemotherapy in the treatment of colorectal cancer. However, some previous studies suggested the combination of the two antibodies may have a negative interaction.

5 Jun 2018

Acoustic technology could offer new way to diagnose IBS

Utilizing newly adapted artificial intelligence, researchers have developed an acoustic belt that offers a new way to diagnose irritable bowel syndrome by listening to the noises in a patient's gut, according to research presented at Digestive Disease Week 2018.

5 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Research sheds light on genetic characteristics of Indonesia's rotavirus

Rotavirus A causes acute diarrhea in young children, and infects both animals and humans worldwide. A Japanese research group has found that the acute gastroenteritis infecting children in Indonesia between 2015 and 2016 was caused by dominant strains of equine-like G3 rotavirus, genetically different from human strains of the virus.

31 May 2018

Preventing Campylobacter infections from chicken eggs

Eggs are a popular food. In fact, Germans consumed almost 20 billion of them in 2016, which equates to a per capita consumption of 235 eggs.

31 May 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

NIH commences first-in-human trial evaluating experimental treatment for Ebola

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

24 May 2018

Unnecessary antibiotic use for asthma exacerbations linked to increased hospital stays, costs

Administering antibiotics to adults hospitalized with an asthma exacerbation without any documented indication of lung infection appears to lengthen hospital stay, increase cost and result in increased risk for antibiotic-related diarrhea, according to new research presented at the ATS 2018 International Conference.

23 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet.

22 May 2018

Few parents use simple strategies to protect kids from food poisoning, reports study

No parent wants to come home from a picnic or restaurant with a little one whose stomachache turns into much worse.

21 May 2018

New study shows link between blood type and severity of diarrhea caused by E. coli

A new study shows that a kind of E. coli most associated with "travelers' diarrhea" and children in underdeveloped areas of the world causes more severe disease in people with blood type A.

18 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

Researchers find new pig virus to be possible threat to humans

A recently identified pig virus can readily find its way into laboratory-cultured cells of people and other species, a discovery that raises concerns about the potential for outbreaks that threaten human and animal health.

15 May 2018

Research may pave way for new C. diff antitoxins and anti-cancer drugs

Researchers from the University of California, Irvine and Harvard University have discovered how the Clostridium difficile toxin B recognizes the human Frizzled protein, the receptor it uses to invade intestinal cells and lead to deadly gastrointestinal infections.

14 May 2018

Diarrhea News and Research

Latest Diarrhea News and Research

On-site pathology testing benefits remote Australians and helps save millions

New FDA-approved therapy provides better quality of life for patients with midgut neuroendocrine tumors

Cedars-Sinai study identifies gut gas associated with diarrhea

Researchers explore targeted second-line treatment for colorectal cancer

Acoustic technology could offer new way to diagnose IBS

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Research sheds light on genetic characteristics of Indonesia's rotavirus

Preventing Campylobacter infections from chicken eggs

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

NIH commences first-in-human trial evaluating experimental treatment for Ebola

Unnecessary antibiotic use for asthma exacerbations linked to increased hospital stays, costs

Celgene to share new and updated data around novel hematological therapies

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Few parents use simple strategies to protect kids from food poisoning, reports study

New study shows link between blood type and severity of diarrhea caused by E. coli

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

Researchers find new pig virus to be possible threat to humans

Research may pave way for new C. diff antitoxins and anti-cancer drugs

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Diarrhea News and Research

Latest Diarrhea News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in